This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Glsynthesis Inc.. Active years: 2005-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Worcester, MA (US) (2005)
- Shrewsbury, MA (US) (2014)
Company Filing History:
Years Active: 2005-2014
Title: Innovations by Wei-Chu Xu in Antibacterial Compounds
Introduction
Wei-Chu Xu is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of antibacterial agents, focusing on innovative compounds that target various bacterial infections. With a total of 2 patents, his work is pivotal in advancing medical treatments.
Latest Patents
Wei-Chu Xu's latest patents include "Selective antibacterials for clostridium difficile infections" and "Purine and isosteric antibacterial compounds." The first patent features compounds that serve as effective antibacterial agents, particularly against clostridium difficile infections. The second patent discloses compounds with potent antimicrobial properties, inhibiting DNA polymerase IIIC and DNA polymerase IIIE enzymes, thereby preventing the growth of a wide range of bacteria.
Career Highlights
Wei-Chu Xu is associated with Glsynthesis Inc., where he continues to develop innovative solutions in the field of antibacterial research. His work has the potential to significantly impact the treatment of bacterial infections in various settings, including eukaryotic cell cultures, animals, and humans.
Collaborations
Throughout his career, Wei-Chu Xu has collaborated with notable colleagues such as George Edward Wright and Neal C Brown. These collaborations have further enriched his research and development efforts in antibacterial compounds.
Conclusion
Wei-Chu Xu's contributions to antibacterial research through his innovative patents highlight his role as a key inventor in the field. His work not only addresses pressing medical challenges but also paves the way for future advancements in antibacterial treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile